Drug Trial Radar · NCT06598943
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Oct 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
143
Planned (sponsor's estimate)
Start
Oct 10, 2024
Primary completion
Aug 3, 2026
Study completion Jul 2027
Sponsor
- Lead sponsor
- Eli Lilly and CompanyEli Lilly (LLY)
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to determine the safety and efficacy of eltrekibart and mirikizumab in adult participants with moderately to severely active ulcerative colitis (UC).
Conditions
- Ulcerative Colitis
- Ulcerative Colitis Chronic
Interventions
EltrekibartDrug
Administered
MirikizumabDrug
Administered
PlaceboDrug
Administered
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving Clinical RemissionTime frame: Week 12
Locations
207 sites in 21 countries. Site status is shown where the registry gives one.
AZ Gastro Care - Chandler
Chandler, Arizona
Applied Research Center of Arkansas
Little Rock, Arkansas
Preferred Research Partners
Little Rock, Arkansas
Erick Alayo Medical Corp/Gastro SB Clinic
Chula Vista, California
Southern California GI and Liver Centers (SCLC)
Coronado, California
Valley View Research
Garden Grove, California
Om Research, LLC
Lancaster, California
United Medical Doctors
Los Alamitos, California
Clinnova Research
Orange, California
Prospective Research Innovations
Rancho Cucamonga, California
Clinical Trials Management Services, LLC
Thousand Oaks, California
Om Research LLC
Victorville, California
Peak Gastroenterology Associates
Colorado Springs, Colorado
Medical Research Center of Connecticut, LLC
Hamden, Connecticut
Novum Research, LLC
Clermont, Florida
I.V.A.M. Clinical & Investigational Center, LLC
Doral, Florida
Florida Research Institute
Lakewood Rch, Florida
Well Pharma Medical Research Corp.
Miami, Florida
Reserka
Miami, Florida
Digestive Disease Consultants DDCJAX
Orange Park, Florida
Orlando Health Digestive Health Institute
Orlando, Florida
AdventHealth Orlando
Orlando, Florida
Nodal Medical Center
Tampa, Florida
Research Bay,Inc.
Tampa, Florida
GCP Clinical Research, LLC
Tampa, Florida
International Center for Research LLC
Tampa, Florida
Northwestern University
Chicago, Illinois
Avicenna Clinical Research - SW Gastroenterology
Oak Lawn, Illinois
Clinical Trials Management, LLC
Metairie, Louisiana
Gastroenterology Associates of Western Michigan, P.L.C.
Wyoming, Michigan
Ellipsis Research Group
Brooklyn, New York
Smart Medical Research - Jackson Heights
Jackson Heights, New York
Pioneer Clinical Research NY
New York, New York
Digestive Disease Medicine of Central New York
Utica, New York
University of North Carolina
Chapel Hill, North Carolina
GCGA Physicians, LLC dba / Gastro Health Research
Cincinnati, Ohio
NexGen Research
Lima, Ohio
Inquest Clinical Research
Baytown, Texas
DHR Health Gastroenterology - Edinburg
Edinburg, Texas
Baylor College of Medicine
Houston, Texas
Showing 40 of 207 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.